Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 1286246, 11 pages
https://doi.org/10.1155/2017/1286246
Review Article

Hematopoietic Stem Cell Transplantation: A Bioethical Lens

1Institute of Hematology, Department of Medical and Surgical Sciences, University of Foggia, Viale Pinto 1, 71122 Foggia, Italy
2Department of Morphology, Experimental Medicine and Surgery, University of Ferrara, Via Fossato di Mortara 70, 44121 Ferrara, Italy
3Institute of Legal Medicine, Department of Clinical and Experimental Medicine, University of Foggia, Ospedale ‘Colonnello D'Avanzo’, Viale Degli Aviatori 1, 71122 Foggia, Italy
4Istituto Clinico-Scientifico Malzoni, 83100 Avellino, Italy
5Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza University of Rome, Viale Regina Elena 336, 00185 Rome, Italy

Correspondence should be addressed to Emanuela Turillazzi; ti.dniwni@izzallirut_aleuname

Received 11 February 2017; Revised 22 March 2017; Accepted 15 May 2017; Published 27 June 2017

Academic Editor: Gerald A. Colvin

Copyright © 2017 Arcangelo Liso et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. K. Singh and J. P. McGuirk, “Allogeneic stem cell transplantation: a historical and scientific overview,” Cancer Research, vol. 76, no. 22, pp. 6445–6451, 2016, [Epub ahead of print]. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Nivison-Smith, P. Bardy, A. J. Dodds et al., “Review of hematopoietic cell transplantation in Australia and New Zealand, 2005 to 2013,” Biology of Blood and Marrow Transplantation, vol. 22, pp. 284–291, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. E. J. Chow, L. Anderson, K. S. Baker et al., “Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a Children’s oncology group report,” Biology of Blood and Marrow Transplantation, vol. 22, pp. 782–795, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Joshi, B. N. Savani, E. J. Chow et al., “Clinical guide to fertility preservation in hematopoietic cell transplant recipients,” Bone Marrow Transplantation, vol. 49, pp. 477–484, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Ruggeri, “Alternative donors: cord blood for adults,” Seminars in Hematology, vol. 53, pp. 65–73, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Giralt, L. Garderet, B. Durie et al., “American society of blood and marrow transplantation, european society of blood and marrow transplantation, blood and marrow transplant clinical trials network, and international myeloma working group consensus conference on salvage hematopoietic cell transplantation in patients with relapsed multiple myeloma,” Biology of Blood and Marrow Transplantation, vol. 21, no. 12, pp. 2039–2051, 2015. View at Google Scholar
  7. A. Chybicka, “Quality of life and ethical and legal dilemmas in children during and after hematopoietic SCT procedure,” Bone Marrow Transplantation, vol. 42, Supplement 2, pp. S87–S89, 2008. View at Google Scholar
  8. G. Caocci, G. La Nasa, E. d'Aloja et al., “Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients,” BMC Medical Ethics, vol. 12, p. 4, 2011. View at Google Scholar
  9. M. M. Horowitz, “Uses and growth of hematopoietic cell transplantation,” Thomas’ Hemopoietic Cell Transplantation, Blackwell Science, Oxford, 3rd edition, 2004. View at Google Scholar
  10. A. Gratwohl, H. Baldomero, M. Aljurf et al., “Hematopoietic stem cell transplantation: a global perspective,” Journal of the American Medical Association, vol. 303, no. 16, pp. 1617–1624, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Niederwieser, H. Baldomero, J. Szer et al., “Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey,” Bone Marrow Transplantation, vol. 51, no. 6, pp. 778–785, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Gratwohl, M. C. Pasquini, M. Aljurf et al., “One million haemopoietic stem-cell transplants: a retrospective observational study,” Lancet Haematology, vol. 2, no. 3, pp. e91–100, 2015. View at Publisher · View at Google Scholar
  13. G. Jaimovich, J. M. Rolon, H. Baldomero et al., “Latin America: the next region for haematopoietic transplant progress,” Bone Marrow Transplantation, vol. 52, no. 5, p. 798, 2017, Epub ahead of print. View at Publisher · View at Google Scholar
  14. A. A. Hussein, A. A. Hamidieh, A. Elhaddad et al., “First report of pediatric hematopoietic stem cell transplantation activities in the Eastern Mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the Eastern Mediterranean blood and marrow transplantation group,” Bone Marrow Transplantation, vol. 52, no. 1, pp. 120–125, 2017. View at Google Scholar
  15. J. R. Passweg, H. Baldomero, M. Bregni et al., “Hematopoietic SCT in Europe: data and trends in 2011,” Bone Marrow Transplantation, vol. 48, no. 9, pp. 1161–1167, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Gratwohl, J. Passweg, H. Baldomero, B. Horisberger, A. Urbano-Ispizua, and Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT), “Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe,” British Journal of Haematology, vol. 117, no. 2, pp. 451–468, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Gratwohl, H. Baldomero, K. Frauendorfer, D. Niederwieser, Joint Accreditation Committee of the International Society for Cellular Therapy ISCT, and European Group for Blood and Marrow Transplantation EMBT (JACIE), “Why are there regional differences in stem cell transplantation activity? An EBMT analysis,” Bone Marrow Transplantation, vol. 42, Supplement 1, pp. S7–S10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. European Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004, “Setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of tissues and cells,” Official Journal of the European Union, vol. 47, 2004. View at Google Scholar
  19. European Directive 2006/17/EC of 8 February 2006, “Implementing Directive of the European Parliament and of Council as regards certain technical requirements for the donation, procurement and control of tissues and cells,” Official Journal of the European Union, vol. 49, 2006. View at Google Scholar
  20. European Directive 2006/86/EC of 24 October 2006, “Implementing Directive 2004/23/EC of the European Parliament and of Council as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells,” Official Journal of the European Union, vol. 49, 2006. View at Google Scholar
  21. E. B. Austin, M. Guttridge, D. Pamphilon, and S. M. Watt, “The role of blood services and regulatory bodies in stem cell transplantation,” Vox Sanguinis, vol. 94, no. 1, pp. 6–17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Chabannon, D. Pamphilon, C. Vermylen et al., “Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program,” Bone Marrow Transplantation, vol. 47, no. 1, pp. 15–17, 2012. View at Google Scholar
  23. A. Gratwohl, R. Brand, E. McGrath et al., “Use of the quality management system “JACIE” and outcome after hematopoietic stem cell transplantation,” Haematologica, vol. 99, no. 5, pp. 908–915, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Samson, I. Slaper-Cortenbach, D. Pamphilon, E. McGrath, F. Mc Donald, and A. Urbano Ispizua, “Current status of JACIE accreditation in Europe: a special report from the Joint Accreditation Committee of the ISCT and the EBMT (JACIE),” Bone Marrow Transplantation, vol. 39, no. 3, pp. 133–141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Pamphilon, J. F. Apperley, D. Samson, I. Slaper-Cortenbach, and E. McGrath, “JACIE accreditation in 2008: demonstrating excellence in stem cell transplantation,” Hematology/Oncology and Stem Cell Therapy, vol. 2, no. 2, pp. 311–319, 2009. View at Publisher · View at Google Scholar
  26. L. Lombardini, A. Bosi, S. Grosz et al., “Haematopoietic stem cell transplantation: a comparison between the accreditation process performed by competent authorities and JACIE in Italy,” Vox Sanguinis, vol. 105, no. 2, pp. 174–176, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Johnson and H. McKenzie, “How I treat advanced classical Hodgkin lymphoma,” Blood, vol. 125, pp. 1717–1723, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Sankaranarayanan and P. Boffetta, “Research on cancer prevention, detection and management in low and medium-income countries,” Annals of Oncology, vol. 21, pp. 1935–1943, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. K. D. Miller, R. L. Siegel, C. C. Lin et al., “Cancer treatment and survivorship statistics, 2016,” CA: A Cancer Journal for Clinicians, vol. 66, pp. 271–289, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. S. F. Wahid, “Indications and outcomes of reduced-toxicity hematopoietic stem cell transplantation in adult patients with hematological malignancies,” International Journal of Hematology, vol. 97, pp. 581–598, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. A. J. Innes, D. Milojkovic, and J. F. Apperley, “Allogeneic transplantation for CML in the TKI era: striking the right balance,” Nature Reviews. Clinical Oncology, vol. 13, pp. 79–91, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. S. B. Rafnsson and R. S. Bhopal, “Migrant and ethnic health research: report on the European Public Health Association Conference 2007,” Public Health, vol. 122, pp. 532–534, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Szczepura, “Access to health care for ethnic minority populations,” Postgraduate Medical Journal, vol. 81, pp. 141–147, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. J. R. Betancourt, A. R. Green, J. E. Carrillo, and O. Ananeh-Firempong 2nd, “Defining cultural competence: a practical framework for addressing racial/ethnic disparities in health and health care,” Public Health Reports, vol. 118, pp. 293–302, 2003. View at Publisher · View at Google Scholar
  35. H. Alzubaidi, K. Mc Namara, C. Browning, and J. Marriott, “Barriers and enablers to healthcare access and use among Arabic-speaking and Caucasian English-speaking patients with type 2 diabetes mellitus: a qualitative comparative study,” BMJ Open, vol. 5, article e008687, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Scheppers, E. van Dongen, J. Dekker, J. Geertzen, and J. Dekker, “Potential barriers to the use of health services among ethnic minorities: a review,” Family Practice, vol. 23, pp. 325–348, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. J. J. Wynn and C. E. Alexander, “Increasing organ donation and transplantation: the U.S. experience over the past decade,” Transplant International, vol. 24, no. 4, pp. 324–332, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. J. Irving, A. Tong, S. Jan et al., “Factors that influence the decision to be an organ donor: a systematic review of the qualitative literature,” Nephrology, Dialysis, Transplantation, vol. 27, no. 6, pp. 2526–2533, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. W. A. Lam and L. B. McCullough, “Influence of religious and spiritual values on the willingness of Chinese-Americans to donate organs for transplantation,” Clinical Transplantation, vol. 14, pp. 449–456, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. S. E. Morgan and T. Cannon, “African Americans’ knowledge about organ donation: closing the gap with more effective persuasive message strategies,” Journal of the National Medical Association, vol. 95, pp. 1066–1071, 2003. View at Google Scholar
  41. A. Salim, D. Schulman, E. J. Ley, C. Berry, S. Navarro, and L. S. Chan, “Contributing factors for the willingness to donate organs in the Hispanic American population,” Archives of Surgery, vol. 145, no. 7, pp. 684–689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. L. A. Siminoff and C. M. Saunders Sturm, “African-American reluctance to donate: beliefs and attitudes about organ donation and implications for policy,” Kennedy Institue of Ethics Journal, vol. 10, no. 1, pp. 59–74, 2000, 12. View at Google Scholar
  43. M. E. Glasgow and G. Bello, “Bone marrow donation: factors influencing intentions in African Americans,” Oncology Nursing Forum, vol. 34, no. 2, pp. 3693–3677, 2007, 13. View at Publisher · View at Google Scholar
  44. W. J. Minniefield, J. Yang, and P. Muti, “Differences in attitudes toward organ donation among African Americans and whites in the United States,” Journal of the National Medical Association, vol. 93, no. 10, pp. 372–379, 2001. View at Google Scholar
  45. S. E. Morgan, “Many facets of reluctance: African Americans and the decision (not) to donate organs,” Journal of the National Medical Association, vol. 98, no. 5, pp. 695–703, 2006. View at Google Scholar
  46. G. E. Switzer, M. A. Dew, and D. J. Harrington, “Ethnic differences in donation-related characteristics among potential hematopoietic stem cell donors,” Transplantation, vol. 80, no. 7, pp. 890–896, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Molassiotis and E. Holroyd, “Assessment of psychological adjustment in Chinese unrelated bone marrow donors,” Bone Marrow Transplantation, vol. 24, pp. 903–910, 1999. View at Publisher · View at Google Scholar
  48. G. S. Switzer, M. A. Dew, A. A. Stukas, J. M. Goycoolea, J. Hegland, and R. Simmons, “Factors associated with attrition from a national bone marrow registry,” Bone Marrow Transplantation, vol. 24, no. 3, pp. 313–319, 1999. View at Publisher · View at Google Scholar
  49. B. Elger and L. Cabrera, “Ethical ways to increase donation of haematopoietic stem cells,” Bioethica Forum, vol. 5, no. 3, pp. 92–99, 2012. View at Google Scholar
  50. E. W. Petersdorf, E. M. Mickelson, C. Anasetti, P. J. Martin, A. E. Woolfrey, and J. A. Hansen, “Effect of HLA mismatches on the outcome of hematopoietic transplants,” Current Opinion in Immunology, vol. 11, pp. 521–610, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. E. W. Petersdorf, “Optimal HLA matching in hematopoietic cell,” Current Opinion in Immunology, vol. 20, pp. 588–593, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Fürst, C. Müller, V. Vucinic et al., “High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis,” Blood, vol. 122, pp. 3220–3910, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Boo, S. M. van Walraven, J. Chapman et al., “Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association,” Blood, vol. 117, no. 1, pp. 21–25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Romagnoli, T. Bart, P. Buerkli, and J. Halter, “Considérations éthiques et juridiques sur les modalités du don dans la transplantation,” Jusletter, vol. 29, 2011. View at Google Scholar
  55. J. Kwok, E. Leung, W. Wong et al., “Factors influencing hematopoietic stem cell donation intention in Hong Kong: a web-based survey,” Annals of Transplantation, vol. 20, pp. 604–613, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. S. S. Tan, C. A. Uyl de-Groot, P. C. Huijgens, and W. E. Fibbe, “Stem cell transplantation in Europe: trends and prospects,” European Journal of Cancer, vol. 43, no. 16, pp. 2359–2365, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Bhandari, A. Lindley, D. Bhatla et al., “Awareness of cord blood collection and the impact on banking,” Pediatric Blood & Cancer, 2017, [Epub ahead of print]. View at Publisher · View at Google Scholar
  58. C. Petrini, “Umbilical cord blood banking: from personal donation to international public registries to global bioeconomy,” Journal of Blood Medicine, vol. 5, pp. 87–97, 2014. View at Publisher · View at Google Scholar
  59. M. G. Butler and J. E. Menitove, “Umbilical cord blood banking: an update,” Journal of Assisted Reproduction and Genetics, vol. 28, no. 8, pp. 669–676, 2011. View at Google Scholar
  60. K. K. Ballen, F. Verter, and J. Kurtzberg, “Umbilical cord blood donation: public or private?” Bone Marrow Transplantation, vol. 50, no. 10, pp. 1271–1278, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. P. Narayanan, A. Wolanskyj, S. L. Ehlers et al., “Medical students’ knowledge, familiarity, and attitudes towards hematopoietic stem cell donation: stem cell donation behaviors,” Biology of Blood and Marrow Transplantation, vol. 22, no. 9, pp. 1710–1716, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. Z. Kaya, K. E. Gültekin, O. K. Demirtaş, D. Karadeniz, Y. Çalapkulu, and Ö. Tap, “Effects of targeted education for first-year university students on knowledge and attitudes about stem cell transplantation and donation,” Experimental and Clinical Transplantation, vol. 13, no. 1, pp. 76–81, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Rosenmayr, L. Hartwell, and T. Egeland, “Informed consent­suggested procedures for informed consent for unrelated haematopoietic stem cell donors at various stages of recruitment, donor evaluation, and donor workup,” Bone Marrow Transplantation, vol. 31, no. 7, pp. 539–545, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. B. E. Shaw, L. Ball, M. Beksac et al., “Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations,” Bone Marrow Transplantation, vol. 45, no. 5, pp. 832–838, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. D. W. Hanto, “Ethical challenges posed by the solicitation of deceased and living organ donors,” The New England Journal of Medicine, vol. 356, no. 10, pp. 1062–1066, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Steinbrook, “Public solicitation of organ donors,” The New England Journal of Medicine, vol. 353, pp. 441–444, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Frunza, K. Van Assche, A. Lennerling et al., “Dealing with public solicitation of organs from living donors—an ELPAT view,” Transplantation, vol. 99, no. 10, pp. 2210–2214, 2015. View at Publisher · View at Google Scholar · View at Scopus
  68. A. D'Souza, M. Pasquini, and R. Spellecy, “Is ‘informed consent’ an ‘understood consent’ in hematopoietic cell transplantation?” Bone Marrow Transplantation, vol. 50, pp. 10–14, 2015. View at Google Scholar
  69. S. Pisu, G. Caocci, E. d'Aloja et al., “Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients,” Philosophy, Ethics, and Humanities in Medicine, vol. 9, p. 13, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. R. Roache, “Why is informed consent important?” Journal of Medical Ethics, vol. 40, pp. 435-436, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. E. Turillazzi and M. Neri, “Informed consent and Italian physicians: change course or abandon ship—from formal authorization to a culture of sharing,” Medicine, Health Care, and Philosophy, vol. 18, pp. 449–453, 2015. View at Publisher · View at Google Scholar · View at Scopus
  72. R. B. Freeman and J. T. Cohen, “Transplantation risks and the real world: what does ‘high risk’ really mean?” American Journal of Transplantation, vol. 9, pp. 23–30, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. P. J. Stiff, L. A. Miller, P. Mumby et al., “Patients’ understanding of disease status and treatment plan at initial hematopoietic stem cell transplantation consultation,” Bone Marrow Transplantation, vol. 37, pp. 479–484, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. S. J. Lee, D. Fairclough, J. H. Antin, and J. C. Weeks, “Discrepancies between patient and physician estimates for the success of stem cell transplantation,” Journal of the American Medical Association, vol. 285, pp. 1034–1038, 2001. View at Publisher · View at Google Scholar
  75. M. A. Andrykowski, M. M. Bishop, E. A. Hahn et al., “Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation,” Journal of Clinical Oncology, vol. 23, pp. 599–608, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Norkin, J. W. Hsu, and J. R. Wingard, “Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation,” Seminars in Hematology, vol. 49, pp. 104–109, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. N. Grulke and H. Bailer, “Facing haematopoietic stem-cell transplantation: do patients and their physicians agree regarding the prognosis?” Psychooncology, vol. 19, pp. 1035–1043, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. T. L. Beauchamp and J. F. Childress, Principles of Biomedical Ethics, Oxford University Press, Oxford (U.K.), 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. J. Pidala, C. Anasetti, and H. Jim, “Quality of life after allogeneic hematopoietic cell transplantation,” Blood, vol. 114, pp. 7–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. J. M. Prieto, J. Atala, J. Blanch et al., “Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation,” Bone Marrow Transplantation, vol. 35, pp. 307–314, 2005. View at Google Scholar
  81. A. R. El-Jawahri, H. B. Vandusen, L. N. Traeger et al., “Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation,” Cancer, vol. 122, pp. 806–812, 2016. View at Publisher · View at Google Scholar · View at Scopus
  82. L. Brice, N. Gilroy, G. Dyer, and M. KabirM. Greenwood, S. Larsen, J. Moore et al., “Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?” Support Care Cancer, vol. 25, pp. 421–427, 2017. View at Publisher · View at Google Scholar
  83. V. Valkova, J. Jircikova, M. Trnkova et al., “The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study,” Neoplasma, vol. 63, pp. 743–751, 2016. View at Publisher · View at Google Scholar · View at Scopus
  84. R. C. Barfield, K. A. Kasow, and G. A. Hale, “Advances in pediatric hematopoietic stem cell transplantation,” Cancer Biology & Therapy, vol. 7, pp. 1533–1539, 2008. View at Google Scholar
  85. T. A. Ratko, S. E. Belinson, H. M. Brown et al., Hematopoietic Stem-Cell Transplantation in the Pediatric Population [Internet], Agency for Healthcare Research and Quality (US), Rockville (MD), 2012, Report No.: 12-EHC018-EF.
  86. F. Locatelli, G. Giorgiani, A. Di-Cesare-Merlone, P. Merli, V. Sparta, and F. Moretta, “The changing role of stem cell transplantation in childhood,” Bone Marrow Transplantation, vol. 41, pp. S3–S7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. R. C. Reulen, D. L. Winter, C. Frobisher et al., “Long-term cause-specific mortality among survivors of childhood cancer,” Journal of the American Medical Association, vol. 304, pp. 172–179, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. Committee On Bioethics, “Informed consent in decision-making in pediatric practice,” Pediatrics, vol. 138, no. 2, 2016. View at Publisher · View at Google Scholar · View at Scopus
  89. P. A. Michaud, K. Berg-Kelly, A. Macfarlane, and L. Benaroyo, “Ethics and adolescent care: an international perspective,” Current Opinion in Pediatrics, vol. 22, pp. 418–422, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. E. Kodish, J. Lantos, C. Stocking, P. A. Singer, M. Siegler, and F. L. Johnson, “Bone marrow transplantation for sickle cell disease. A study of parents decisions,” The New England Journal of Medicine, vol. 325, pp. 1349–1353, 1991. View at Publisher · View at Google Scholar
  91. K. van Besien, M. Koshy, L. Anderson-Shaw et al., “Allogeneic stem cell transplantation for sickle cell disease. A study of patients decisions,” Bone Marrow Transplantation, vol. 28, pp. 545–549, 2001. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Roth, J. Krystal, D. Manwani, C. Driscoll, and R. Ricafort, “Stem cell transplant for children with sickle cell anemia: parent and patient interest,” Biology of Blood and Marrow Transplantation, vol. 18, pp. 1709–1715, 2012. View at Publisher · View at Google Scholar · View at Scopus
  93. E. R. Meier, J. V. Dioguardi, and N. Kamani, “Current attitudes of parents and patients toward hematopoietic stem cell transplantation for sickle cell anemia,” Pediatric Blood & Cancer, vol. 62, pp. 1277–1284, 2015. View at Publisher · View at Google Scholar · View at Scopus
  94. C. Doig and E. Burgess, “Withholding life-sustaining treatment: are adolescents competent to make these decisions?” Canadian Medical Association Journal, vol. 162, pp. 1585–1588, 2000. View at Google Scholar
  95. M. R. Mercurio, “An adolescent’s refusal of medical treatment: implications of the Abraham Cherrix case,” Pediatrics, vol. 120, pp. 1357-1358, 2007. View at Publisher · View at Google Scholar · View at Scopus
  96. L. F. Ross, “Against the tide: arguments against respecting a minor’s refusal of efficacious life-saving treatment,” Cambridge Quarterly of Healthcare Ethics, vol. 18, pp. 302–315, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. C. Johnston, “Overriding competent medical treatment refusal by adolescents: when ‘no’ means ‘no’,” Archives of Disease in Childhood, vol. 94, pp. 487–491, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. P. Alderson, “Competent children? Minors consent to health care treatment and research,” Social Science & Medicine, vol. 65, pp. 2272–2283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. N. Lennings, “Children and refusal of medical treatment: in urgent need of reform,” Journal of Law and Medicine, vol. 21, pp. 122–141, 2013. View at Google Scholar
  100. L. Iffy, V. Varadi, N. Portuondo, and N. Ende, “Collection of fetal blood for stem cell research and therapy,” Medicine and Law, vol. 25, pp. 553–561, 2006. View at Google Scholar
  101. J. Lexchin, L. A. Bero, B. Djulbegovic, and O. Clark, “Pharmaceutical industry sponsorship and research outcome and quality: systematic review,” British Medical Journal, vol. 326, pp. 1167–1170, 2003. View at Publisher · View at Google Scholar
  102. M. Markman and J. DeMarco, “Potential conflict between fundamental ethical principles and requirements of the oncology drug approval process: ethical conflict in drug approval,” Cancer, vol. 98, pp. 215–218, 2003. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Droste, A. Herrmann-Frank, F. Scheibler, and T. Krones, “Ethical issues in autologous stem cell transplantation (ASCT) in advanced breast cancer: a systematic literature review,” BMC Medical Ethics, vol. 12, p. 6, 2011. View at Google Scholar